X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
1. 4-(diethylamino)-2-butynyl-alpha-cyclohexyl-alpha-hydroxybenzeneacetate
2. 4-(diethylamino)-2-butynyl-alpha-phenylcyclohexaneglycolate
3. Apo-oxybutynin
4. Contimin
5. Cystonorm
6. Cystrin
7. Ditropan
8. Dresplan
9. Dridase
10. Driptane
11. Gelnique
12. Gen-oxybutynin
13. Novo-oxybutynin
14. Nu-oxybutyn
15. Oxyb Abz
16. Oxybugamma
17. Oxybutin Holsten
18. Oxybuton
19. Oxybutynin
20. Oxybutynin Al
21. Oxybutynin Azu
22. Oxybutynin Heumann
23. Oxybutynin Hexal
24. Oxybutynin Hydrochloride
25. Oxybutynin Stada
26. Oxybutynin Von Ct
27. Oxybutynin-puren
28. Oxybutynin-ratiopharm
29. Oxymedin
30. Oxytrol
31. Pms-oxybutynin
32. Pollakisu
33. Renamel
34. Ryol
35. Spasmex Oxybutynin
36. Spasyt
37. Tavor
38. Zatur
1. Oxybutynin Hydrochloride
2. 1508-65-2
3. Oxybutynin Hcl
4. Tropax
5. Oxybutynin (chloride)
6. Ditropan Xl
7. Pollakisu
8. Mj 4309-1
9. L9f3d9renq
10. Nsc-759108
11. Alpha-phenylcyclohexaneglycolic Acid 4-(diethylamino)-2-butynyl Ester Hydrochloride
12. Mls000069688
13. 4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate Hydrochloride
14. Dridase
15. Smr000058490
16. Mj-4309-1
17. 4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate;hydrochloride
18. Oxybutynin Hydrochloride (jan)
19. 4-diethylamino-2-butynyl Phenyl(cyclohexyl)glycolate Hydrochloride
20. 4-(diethylamino)-2-butynyl Alpha-phenylcyclohexaneglycolate Hydrochloride
21. Gelnique
22. Oxibutinina Hydrochloride
23. Oxybutynin Hydrochloride [jan]
24. Chebi:7857
25. 4-diethylaminobut-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylethanoate Hydrochloride
26. Oxybutynin Chloride [usan]
27. Oxybutyninhydrochloride
28. Sr-01000000184
29. Einecs 216-139-7
30. Unii-l9f3d9renq
31. 4-(diethylamino)but-2-ynyl Cyclohexylphenylglycolate Hydrochloride
32. Oxybutynin Chloride [usan:usp]
33. Ditropan (tn)
34. Gelnique (tn)
35. Prestwick_621
36. Mfcd00072150
37. Oxybutynin-d11 Hcl
38. 4-(diethylamino)but-2-yn-1-yl Cyclohexyl(hydroxy)phenylacetate Hydrochloride
39. Opera_id_1330
40. Ncgc00016583-01
41. Oxybutynin (hydrochloride)
42. Oxybutynin Chloride (usp)
43. Cas-1508-65-2
44. Chembl1133
45. Dsstox_cid_25356
46. Dsstox_rid_80822
47. Dsstox_gsid_45356
48. Schembl25751
49. Mls001148211
50. Mls002222232
51. Regid_for_cid_91505
52. Dtxsid3045356
53. Hy-b0267a
54. (s)-4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate Hydrochloride
55. Hms1568j16
56. Pharmakon1600-01505399
57. (r,s) - Oxybutynin Hydrochloride
58. Oxybutynin Chloride [vandf]
59. Bcp12138
60. Oxybutynin Chloride-(phenyl-[d5])
61. Tox21_110507
62. Tox21_500923
63. Nsc759108
64. Oxybutynin Chloride [usp-rs]
65. Oxybutynin Hydrochloride [mi]
66. S3117
67. 4-(diethylamino)-2-butynyl (+-)-alpha-phenylcyclohexaneglycolate Hydrochloride
68. Akos015895349
69. Ccg-213420
70. H33o205
71. Ks-1377
72. Lp00923
73. Nc00580
74. Nsc 759108
75. Cyclohexaneglycolic Acid, Alpha-phenyl-, 4-(diethylamino)-2-butynyl Ester, Hydrochloride
76. Oxybutynin Hydrochloride [mart.]
77. Ncgc00094234-01
78. Ncgc00094234-02
79. Ncgc00261608-01
80. Oxybutynin Chloride [orange Book]
81. Oxybutynin Hydrochloride [who-dd]
82. Benzeneacetic Acid, Alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl Ester Hydrochloride
83. Benzeneacetic Acid, Alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl Ester Hydrochloride, (+-)-
84. Bo166187
85. Oxybutynin Chloride [usp Impurity]
86. Oxybutynin Chloride [usp Monograph]
87. Eu-0100923
88. Ft-0603563
89. Ft-0673411
90. Ft-0673412
91. O0451
92. Oxybutynin Chloride, >=98% (tlc), Powder
93. Sw196787-4
94. A51042
95. D00722
96. O 2881
97. Oxybutynin Hydrochloride [ep Monograph]
98. Oxybutynin Hydrochloride [usp Impurity]
99. A809082
100. J-008750
101. Sr-01000000184-2
102. Sr-01000000184-7
103. Q27107600
104. Oxybutynin Chloride, Meets Ep, Usp Testing Specifications
105. Oxybutynin Chloride, United States Pharmacopeia (usp) Reference Standard
106. Oxybutynin Hydrochloride, British Pharmacopoeia (bp) Reference Standard
107. Oxybutynin Hydrochloride, European Pharmacopoeia (ep) Reference Standard
108. 2-cyclohexyl-2-hydroxy-2-phenylacetic Acid 4-(diethylamino)but-2-ynyl Ester Hcl
109. 4-(diethylamino)-2-butynyl (+/-)-,alpha.-phenylcyclohexaneglycolate Hydrochloride
110. 4-(diethylamino)but-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate Hydrochloride
111. 4-diethylamino-2-butynylphenyl(cyclohexyl)glycolatehydrochloride;oxybutynin Hcl
112. Alpha-phenylcyclohexaneglycolic Acid 4-(diethylamino)-2-butynyl Ester, Hydrochloride
113. Benezeneactetic Acid, .alpha.-cyclohexyl-.alpha.-hydroxy-,4-(diethylamino-2-butunyl Ester Hydrochloride,(+/-)-
114. Benzeneacetic Acid, .alpha.-cyclohexyl-.alpha.-hydroxy-, 4-(diethylamino)-2-butynyl Ester Hydrochloride, (+/-)-
| Molecular Weight | 393.9 g/mol |
|---|---|
| Molecular Formula | C22H32ClNO3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 8 |
| Exact Mass | 393.2070716 g/mol |
| Monoisotopic Mass | 393.2070716 g/mol |
| Topological Polar Surface Area | 49.8 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 490 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 8 | |
|---|---|
| Drug Name | Ditropan xl |
| Drug Label | DITROPAN XL (oxybutynin chloride) is an antispasmodic, anticholinergic agent. Each DITROPAN XL Extended Release Tablet contains 5 mg, 10 mg, or 15 mg of oxybutynin chloride USP, formulated as a once-a-day controlled-release tablet for oral admini... |
| Active Ingredient | Oxybutynin chloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | 5mg; 10mg; 15mg |
| Market Status | Prescription |
| Company | Janssen Pharms |
| 2 of 8 | |
|---|---|
| Drug Name | Gelnique |
| PubMed Health | Oxybutynin (By mouth) |
| Drug Classes | Urinary Antispasmodic |
| Drug Label | Oxybutynin is an antispasmodic, antimuscarinic agent. GELNIQUE (oxybutynin chloride) is a clear and colorless hydroalcoholic gel containing 100 mg oxybutynin chloride per gram of gel. GELNIQUE is available in a 1 gram (1.14 mL) unit dose that contain... |
| Active Ingredient | Oxybutynin chloride |
| Dosage Form | Gel |
| Route | Transdermal |
| Strength | 10%(100mg/packet) |
| Market Status | Prescription |
| Company | Watson Labs |
| 3 of 8 | |
|---|---|
| Drug Name | Oxybutynin chloride |
| Drug Label | Oxybutynin chloride tablets USP are a debossed, very pale blue, round, biconvex, scored tablet containing 5 mg of oxybutynin chloride, USP. Chemically, oxybutynin chloride is d,l (racemic) 4-diethylamino-2-butynyl phenylcyclohexylglycolate hydrochlor... |
| Active Ingredient | Oxybutynin chloride |
| Dosage Form | Tablet, extended release; Tablet; Syrup |
| Route | Oral |
| Strength | 15mg; 5mg; 10mg; 5mg/5ml |
| Market Status | Prescription |
| Company | Vintage Pharms; Impax Pharms; Mylan Pharms; Wockhardt; Silarx; Pharm Assoc; Teva Pharms Usa; Osmotica Pharm; Usl Pharma; Mylan |
| 4 of 8 | |
|---|---|
| Drug Name | Oxybutynin chloride |
| PubMed Health | Oxybutynin |
| Drug Classes | Urinary Antispasmodic |
| Drug Label | Oxybutynin chloride tablets USP are a debossed, very pale blue, round, biconvex, scored tablet containing 5 mg of oxybutynin chloride, USP. Chemically, oxybutynin chloride is d,l (racemic) 4-diethylamino-2-butynyl phenylcyclohexylglycolate hydrochlor... |
| Active Ingredient | Oxybutynin chloride |
| Dosage Form | Tablet, extended release |
| Route | oral |
| Strength | 15 mg. |
| Market Status | Prescription |
| Company | Mylan Pharms |
| 5 of 8 | |
|---|---|
| Drug Name | Ditropan xl |
| Drug Label | DITROPAN XL (oxybutynin chloride) is an antispasmodic, anticholinergic agent. Each DITROPAN XL Extended Release Tablet contains 5 mg, 10 mg, or 15 mg of oxybutynin chloride USP, formulated as a once-a-day controlled-release tablet for oral admini... |
| Active Ingredient | Oxybutynin chloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | 5mg; 10mg; 15mg |
| Market Status | Prescription |
| Company | Janssen Pharms |
| 6 of 8 | |
|---|---|
| Drug Name | Gelnique |
| PubMed Health | Oxybutynin (By mouth) |
| Drug Classes | Urinary Antispasmodic |
| Drug Label | Oxybutynin is an antispasmodic, antimuscarinic agent. GELNIQUE (oxybutynin chloride) is a clear and colorless hydroalcoholic gel containing 100 mg oxybutynin chloride per gram of gel. GELNIQUE is available in a 1 gram (1.14 mL) unit dose that contain... |
| Active Ingredient | Oxybutynin chloride |
| Dosage Form | Gel |
| Route | Transdermal |
| Strength | 10%(100mg/packet) |
| Market Status | Prescription |
| Company | Watson Labs |
| 7 of 8 | |
|---|---|
| Drug Name | Oxybutynin chloride |
| Drug Label | Oxybutynin chloride tablets USP are a debossed, very pale blue, round, biconvex, scored tablet containing 5 mg of oxybutynin chloride, USP. Chemically, oxybutynin chloride is d,l (racemic) 4-diethylamino-2-butynyl phenylcyclohexylglycolate hydrochlor... |
| Active Ingredient | Oxybutynin chloride |
| Dosage Form | Tablet, extended release; Tablet; Syrup |
| Route | Oral |
| Strength | 15mg; 5mg; 10mg; 5mg/5ml |
| Market Status | Prescription |
| Company | Vintage Pharms; Impax Pharms; Mylan Pharms; Wockhardt; Silarx; Pharm Assoc; Teva Pharms Usa; Osmotica Pharm; Usl Pharma; Mylan |
| 8 of 8 | |
|---|---|
| Drug Name | Oxybutynin chloride |
| PubMed Health | Oxybutynin |
| Drug Classes | Urinary Antispasmodic |
| Drug Label | Oxybutynin chloride tablets USP are a debossed, very pale blue, round, biconvex, scored tablet containing 5 mg of oxybutynin chloride, USP. Chemically, oxybutynin chloride is d,l (racemic) 4-diethylamino-2-butynyl phenylcyclohexylglycolate hydrochlor... |
| Active Ingredient | Oxybutynin chloride |
| Dosage Form | Tablet, extended release |
| Route | oral |
| Strength | 15 mg. |
| Market Status | Prescription |
| Company | Mylan Pharms |
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
Urological Agents
Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)
Market Place
